Mazdutide 5MG

Description

What is Mazdutide?

Mazdutide (IBI362; LY3305677) is a synthetic peptide analogue of oxyntomodulin that acts at GLP-1 and glucagon receptors. It is studied in metabolic and receptor-signalling research.

Check the supplier specification and any available batch-specific analytical documentation for identity, composition and suitability for your laboratory method.

Published study findings and evidence limits

Human trial evidence

A randomised phase 2 trial in Chinese adults with overweight or obesity reported greater body-weight reduction with mazdutide than placebo. Gastrointestinal adverse effects were reported. The population, trial formulation and duration limit how widely the findings can be applied.

Sources: Mazdutide phase 2 trial (2023).

Are benefits proven for this product? No clinical benefit has been established for the research material sold in this listing. Positive results for a characterised study formulation do not validate this batch, its safety or its suitability for human use. Research findings are provided for scientific context.

For research purposes only. Supplied exclusively for laboratory research and analytical use. Not for human or animal consumption, injection, therapeutic, diagnostic or cosmetic use. This product is not supplied as a medicine, food or dietary supplement. Information on this page describes research context and does not establish safety or efficacy for use in people or animals.